44
Participants
Start Date
October 1, 2010
Primary Completion Date
May 1, 2013
Study Completion Date
May 1, 2013
Azacitidine
Subjects will receive azacitidine 75 mg/m2/day SC for 7 days every 28 days for up to 6 cycles, unless they are discontinued from the treatment. In addition, subjects may receive best supportive care as needed, including antibiotics and transfusions, per Investigator discretion.
China Medical University Hospital, Taichung
Changhua Christian Hospital, Changhua
Chiayi Chang Gung Memorial Hospital, Chiayi City
National Cheng Kung University Hospital, Tainan City
Kaohsiung Medical Hospital University, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Buddhist Tzu Chi General Hospital-Hualien Tzu Chi Medical Center, Hualien City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Shuang-ho Hospital, New Taipei City
Lead Sponsor
Celgene
INDUSTRY